During long-term therapy in patients, most of whom had major underlying pathology and multiple concomitant treatments, the incidence of adverse experiences was higher (16.2%). The most frequently reported adverse experiences were of gastrointestinal origin (6.1%), where nausea (2%) and epigastralgia (0.9%) were most commonly reported. A few cases of hypokalaemia have been observed during long-term therapy.
View ADR Monitoring Form